Stockreport

Annovis doubles as lead drug improves Parkinson's [Seeking Alpha]

Annovis Bio, Inc.  (ANVS) 
PDF and effective in improving the physical and cognitive functions of patients with early Parkinson's disease. Updating data from its Phase 3 PD trial, Annovis ( ANVS ) s [Read more]